GeneDx Holdings Corp. Class A Common Stock (WGS) is a publicly traded Healthcare sector company. As of July 5, 2026, WGS trades at $67.51 with a market cap of $2.00B and a P/E ratio of -92.48. WGS moved -5.83% today. Year to date, WGS is -47.26%; over the trailing twelve months it is -24.81%. Its 52-week range spans $32.21 to $170.87. Analyst consensus is strong buy with an average price target of $75.43. Rallies surfaces WGS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for WGS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $67.51 |
| Market Cap | $2.00B |
| P/E Ratio | -92.48 |
| EPS | $-0.73 |
| Dividend Yield | 0.00% |
| 52-Week High | $170.87 |
| 52-Week Low | $32.21 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $427.54M |
| Net Income | $-21.02M |
| Gross Margin | 69.74% |
8 analysts cover WGS: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $75.43.